Literature DB >> 20212481

Lost in migration.

George S Mack, Andrew Marshall.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 20212481     DOI： 10.1038/nbt0310-214

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  29 in total

1.  Regulation of progenitor cell fusion by ABCB5 P-glycoprotein, a novel human ATP-binding cassette transporter.

Authors:  Natasha Y Frank; Shona S Pendse; Peter H Lapchak; Armen Margaryan; Debbie Shlain; Carsten Doeing; Mohamed H Sayegh; Markus H Frank
Journal:  J Biol Chem       Date:  2003-09-07       Impact factor: 5.157

2.  Risks and benefits of phase 1 clinical trials evaluating new anticancer agents: a case for more innovation.

Authors:  Eric X Chen; Ian F Tannock
Journal:  JAMA       Date:  2004-11-03       Impact factor: 56.272

3.  A novel approach to using matrix metalloproteinases for bladder cancer.

Authors:  Cecilia A Fernández; Matthew F Wszolek; Kevin R Loughlin; John A Libertino; Ian C Summerhayes; Anthony P Shuber
Journal:  J Urol       Date:  2009-09-16       Impact factor: 7.450

4.  Antihuman epidermal growth factor receptor 2 antibody herceptin inhibits autocrine motility factor (AMF) expression and potentiates antitumor effects of AMF inhibitors.

Authors:  Amjad H Talukder; Rozita Bagheri-Yarmand; Ruth R E Williams; Jiannis Ragoussis; Rakesh Kumar; Avraham Raz
Journal:  Clin Cancer Res       Date:  2002-10       Impact factor: 12.531

5.  Critical factors in the biology of human cancer metastasis: twenty-eighth G.H.A. Clowes memorial award lecture.

Authors:  I J Fidler
Journal:  Cancer Res       Date:  1990-10-01       Impact factor: 12.701

6.  ABCB5-mediated doxorubicin transport and chemoresistance in human malignant melanoma.

Authors:  Natasha Y Frank; Armen Margaryan; Ying Huang; Tobias Schatton; Ana Maria Waaga-Gasser; Martin Gasser; Mohamed H Sayegh; Wolfgang Sadee; Markus H Frank
Journal:  Cancer Res       Date:  2005-05-15       Impact factor: 12.701

7.  Lipocalin 2 promotes breast cancer progression.

Authors:  Jiang Yang; Diane R Bielenberg; Scott J Rodig; Robert Doiron; Matthew C Clifton; Andrew L Kung; Roland K Strong; David Zurakowski; Marsha A Moses
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-23       Impact factor: 11.205

Review 8.  Potential therapeutic application of chondroitin sulfate/dermatan sulfate.

Authors:  Shuhei Yamada; Kazuyuki Sugahara
Journal:  Curr Drug Discov Technol       Date:  2008-12

9.  Prosaposin inhibits tumor metastasis via paracrine and endocrine stimulation of stromal p53 and Tsp-1.

Authors:  Soo-Young Kang; Ole J Halvorsen; Karsten Gravdal; Nandita Bhattacharya; Jung Min Lee; Nathan W Liu; Brian T Johnston; Adam B Johnston; Svein A Haukaas; Kristie Aamodt; Sun Yoo; Lars A Akslen; Randolph S Watnick
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-06       Impact factor: 11.205

10.  Efficient tumour formation by single human melanoma cells.

Authors:  Elsa Quintana; Mark Shackleton; Michael S Sabel; Douglas R Fullen; Timothy M Johnson; Sean J Morrison
Journal:  Nature       Date:  2008-12-04       Impact factor: 49.962
View more
  25 in total

1.  Biophysical Regulation of Cancer Stem/Initiating Cells: Implications for Disease Mechanisms and Translation.

Authors:  Joseph Chen; Sanjay Kumar
Journal:  Curr Opin Biomed Eng       Date:  2017-05-19

2.  Herceptin functionalized microfluidic polydimethylsiloxane devices for the capture of human epidermal growth factor receptor 2 positive circulating breast cancer cells.

Authors:  Benjamin Thierry; Mahaveer Kurkuri; Jun Yan Shi; Lwin Ei Mon Phyo Lwin; Dennis Palms
Journal:  Biomicrofluidics       Date:  2010-09-30       Impact factor: 2.800

Review 3.  Antiangiogenic therapy: impact on invasion, disease progression, and metastasis.

Authors:  John M L Ebos; Robert S Kerbel
Journal:  Nat Rev Clin Oncol       Date:  2011-03-01       Impact factor: 66.675

4.  In vivo screening of S100B inhibitors for melanoma therapy.

Authors:  Danna B Zimmer; Rena G Lapidus; David J Weber
Journal:  Methods Mol Biol       Date:  2013

5.  Cancer cells display increased migration and deformability in pace with metastatic progression.

Authors:  Zhenhui Liu; Se Jong Lee; Seungman Park; Konstantinos Konstantopoulos; Kristine Glunde; Yun Chen; Ishan Barman
Journal:  FASEB J       Date:  2020-05-28       Impact factor: 5.191

Review 6.  Epithelial-to-mesenchymal transition in thyroid cancer: a comprehensive review.

Authors:  Heewa Shakib; Sadegh Rajabi; Mohammad Hossien Dehghan; Farideh Jalali Mashayekhi; Nahid Safari-Alighiarloo; Mehdi Hedayati
Journal:  Endocrine       Date:  2019-08-04       Impact factor: 3.633

Review 7.  Functions of S100 proteins.

Authors:  R Donato; B R Cannon; G Sorci; F Riuzzi; K Hsu; D J Weber; C L Geczy
Journal:  Curr Mol Med       Date:  2013-01       Impact factor: 2.222

8.  Blockade of extracellular NM23 or its endothelial target slows breast cancer growth and metastasis.

Authors:  Nucharee Yokdang; Senny Nordmeier; Katie Speirs; Heather R Burkin; Iain L O Buxton
Journal:  Integr Cancer Sci Ther       Date:  2015

Review 9.  Mechanosensitive Ion Channels: TRPV4 and P2X7 in Disseminating Cancer Cells.

Authors:  Jacob M Hope; Joshua D Greenlee; Michael R King
Journal:  Cancer J       Date:  2018 Mar/Apr       Impact factor: 3.360

10.  A platelet-mimetic paradigm for metastasis-targeted nanomedicine platforms.

Authors:  Christa L Modery-Pawlowski; Alyssa M Master; Victor Pan; Gregory P Howard; Anirban Sen Gupta
Journal:  Biomacromolecules       Date:  2013-02-14       Impact factor: 6.988
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.